//cobioscience.com/wp-content/uploads/2026/03/Investor-Con-Banner_BioMed-scaled.jpg

Presenting Companies: What to Expect

Presenting Companies

In 2026, nearly 40 presenting health innovation companies will take the stage at the Grand Hyatt Vail, representing Colorado and the broader Rocky Mountain West.

Colorado raised a record-setting $3.2 billion in 2025. The 2026 conference builds on that capital momentum for companies ready to grow, partner, and scale.

If your company is advancing strong science, executing with clarity, and preparing for its next capital milestone, we encourage you to apply. We also encourage emerging life sciences companies not actively raising to take part in the Rocky Mountain Life Sciences Investor & Partnering conference for education and networking opportunities.

Colorado Success Stories Snapshot: Includes 2022 and 2024 Presenting Companies

Enveda
$300M
Closed Series C & D in 2024 and 2025
Foresight Diagnostics
$450M
Acquired by Natera in 2025
RheumaGen
$15M
Closed Series A in 2025
SiVEC Biotechnologies
$3.3M
Closed Seed Round in 2025
Think BioScience
$55M
Closed Series A in 2026

Colorado Success Stories Snapshot: Includes 2022 and 2024 Presenting Companies

2026 Presenting Companies
2024 Presenting Companies
2022 Presenting Companies

Selection Process

All presenting companies are selected through a competitive selection process and complete comprehensive pitch training. A review committee evaluates scientific merit, leadership strength, capital readiness, and growth trajectory.

Round Two Application Period: Open Now

Opened: May 6, 2026
Closes: June 3, 2026

Space is limited. Early application is encouraged.

Who Should Apply to Present?

We invite emerging and growth-stage companies from Colorado and across the Rocky Mountain West that are building scalable, investment-ready life sciences businesses.

Ideal applicants include:

  • Biotech and pharmaceutical companies
  • Medical device, diagnostics, digital health, animal health, and ag bio companies
  • University spinouts and proof-of-concept companies ready to translate breakthrough science into venture-backed growth
  • Innovation-driven companies operating at the intersection of life sciences and advanced technologies

Companies selected to present demonstrate scientific rigor, experienced leadership, a clear development strategy, and defined capital needs.

Post-Selection Requirements

Companies selected to present will:

  • Confirm participation promptly
  • Submit logos, executive bios, and finalized pitch decks
  • Provide marketing materials for promotion and investor outreach

CBSA will promote presenting companies through comprehensive conference communications.